Member

Love this stock. Also bought $SYRS. Read Syros data printout from Dec 10th. 80 plus % response in patients.

Love this stock. Also bought $SYRS. Read Syros data printout from Dec 10th. 80 plus % response in patients.

Love this stock. I also bought $SYRS. Read data printout from Dec 10th. Funded till 2025

$SYRS has plenty of funds to complete studies. Runway to 2025. Buy $SYRS.

$SYRS hits 4 today and the climb to 10 DPS will happen.

$SYRS. Lets all make a profit. Two for two. $SYRS AND $PXMD.

$SYRS and $TXMD are winners. Buy!

I think the timing of their post coincided with the ASHE annual conference. Managements focus is the patients and research first this why the announced on a Saturday.

$SYRS great buy at this price. Amazing results announced. NDA around the corner.

$SYRS is going to do a bull run on Monday.